No. 5 / 2025 Zealand Pharma appoints Utpal Singh as Chief Scientific Officer to drive next-generation peptide therapeutics ...

Key Advances from the Study & Implications for Drug Discovery: -A New Late-Stage Peptide Reshaping Strategy: Developed by Dr. Derda and colleagues, this approach uses a C2-symmetric linchpin KYL ...

Utpal joins Zealand Pharma at a pivotal moment as it aims to become a leader in the management of obesity and related complications He will lead the discovery and clinical translation of peptide ...

In Alzheimer's, Parkinson's, and type 2 diabetes, harmful protein aggregates and deposits, known as amyloid plaques, develop.

Singh will lead the discovery and clinical translation of peptide medicines, investing in new technologies, including data and computational science.

Leveraging AI, researchers have identified a naturally occurring molecule that can suppress appetite and facilitate weight loss in mice and pigs.